Viktor Mravčík

1.2k total citations
61 papers, 479 citations indexed

About

Viktor Mravčík is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Clinical Psychology. According to data from OpenAlex, Viktor Mravčík has authored 61 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 22 papers in Public Health, Environmental and Occupational Health and 12 papers in Clinical Psychology. Recurrent topics in Viktor Mravčík's work include HIV, Drug Use, Sexual Risk (19 papers), Substance Abuse Treatment and Outcomes (17 papers) and Opioid Use Disorder Treatment (13 papers). Viktor Mravčík is often cited by papers focused on HIV, Drug Use, Sexual Risk (19 papers), Substance Abuse Treatment and Outcomes (17 papers) and Opioid Use Disorder Treatment (13 papers). Viktor Mravčík collaborates with scholars based in Czechia, Norway and Portugal. Viktor Mravčík's co-authors include Tomáš Zábranský, Roman Gabrhelík, Svetlana Skurtveit, Marte Handal, Pavla Chomynová, Paul Griffiths, Dominique Lopez, Bernd Schulte, Vladimír Bencko and Jens Reimer and has published in prestigious journals such as Addiction, Drug and Alcohol Dependence and BMJ Open.

In The Last Decade

Viktor Mravčík

50 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Mravčík Czechia 13 263 145 99 97 73 61 479
Linda Montanari Portugal 13 219 0.8× 115 0.8× 54 0.5× 31 0.3× 81 1.1× 34 380
Anthea Martin United Kingdom 11 455 1.7× 260 1.8× 44 0.4× 128 1.3× 39 0.5× 14 615
Nelson Arruda Canada 13 422 1.6× 292 2.0× 49 0.5× 106 1.1× 31 0.4× 22 558
Seyed Ramin Radfar Iran 10 253 1.0× 131 0.9× 24 0.2× 43 0.4× 79 1.1× 27 459
Katherine Rudzinski Canada 14 409 1.6× 234 1.6× 60 0.6× 38 0.4× 77 1.1× 34 625
Nicola Metrebian United Kingdom 11 492 1.9× 479 3.3× 90 0.9× 36 0.4× 45 0.6× 32 734
James Fetherston Australia 9 271 1.0× 170 1.2× 46 0.5× 19 0.2× 37 0.5× 13 424
Tomáš Zábranský Czechia 11 229 0.9× 89 0.6× 16 0.2× 49 0.5× 45 0.6× 22 337
Ifeoma N. Onyeka Finland 13 160 0.6× 113 0.8× 52 0.5× 19 0.2× 90 1.2× 30 380
G.H.A. van Brussel Netherlands 11 257 1.0× 198 1.4× 46 0.5× 20 0.2× 33 0.5× 15 387

Countries citing papers authored by Viktor Mravčík

Since Specialization
Citations

This map shows the geographic impact of Viktor Mravčík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Mravčík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Mravčík more than expected).

Fields of papers citing papers by Viktor Mravčík

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Mravčík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Mravčík. The network helps show where Viktor Mravčík may publish in the future.

Co-authorship network of co-authors of Viktor Mravčík

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Mravčík. A scholar is included among the top collaborators of Viktor Mravčík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Mravčík. Viktor Mravčík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mravčík, Viktor, et al.. (2024). Psychomodulatory substances: New legislative framework for control of psychoactive substances in Czechia. International Journal of Drug Policy. 133. 104603–104603. 2 indexed citations
2.
Skurtveit, Svetlana, et al.. (2024). Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway. Addiction Science & Clinical Practice. 19(1). 37–37.
3.
Terzić-Šupić, Zorica, Jovana Todorović, Biljana Kilibarda, & Viktor Mravčík. (2023). Non-medical prescription drug use in Serbia: Results from the national survey on lifestyles: Substance abuse and gambling. 4(3). 209–221.
4.
Skurtveit, Svetlana, Thomas Clausen, Morten Hesse, et al.. (2023). Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study. European Addiction Research. 29(4). 272–284. 5 indexed citations
5.
Gabrhelík, Roman, Marte Handal, Viktor Mravčík, et al.. (2021). Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study. BMJ Open. 11(5). e047028–e047028. 8 indexed citations
6.
Chomynová, Pavla, Jan Kozák, & Viktor Mravčík. (2020). Substance use in Roma population in contact with social workers in the Czech Republic: A cross-sectional questionnaire survey. Journal of Ethnicity in Substance Abuse. 20(2). 275–294. 4 indexed citations
7.
Gabrhelík, Roman, et al.. (2020). Prenatal Methamphetamine Exposure and Adverse Neonatal Outcomes: A Nationwide Cohort Study. European Addiction Research. 27(2). 97–106. 9 indexed citations
8.
Škařupová, Kateřina, Tomáš Vlach, & Viktor Mravčík. (2020). Early intervention and identification of gambling disorder: a systematic literature review of strategies implemented by gambling operators. Central European Journal of Public Health. 28(1). 18–23. 9 indexed citations
9.
Mravčík, Viktor, et al.. (2020). Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015–2016: A multi-method estimation study. Journal of Substance Abuse Treatment. 122. 108229–108229. 3 indexed citations
10.
Mravčík, Viktor, et al.. (2019). Alcohol use and its consequences in the Czech Republic. Central European Journal of Public Health. 27(Supplement). S15–S28. 12 indexed citations
11.
Chomynová, Pavla, et al.. (2017). Cannabis decriminalization and the age of onset of cannabis use. International Journal of Drug Policy. 43. 122–129. 18 indexed citations
12.
Kilibarda, Biljana, et al.. (2016). E-cigarette use among Serbian adults: prevalence and user characteristics. International Journal of Public Health. 61(2). 167–175. 11 indexed citations
13.
Mravčík, Viktor. (2015). (De)criminalisation of possession of drugs for personal use – A view from the Czech Republic. International Journal of Drug Policy. 26(7). 705–707. 9 indexed citations
14.
Mravčík, Viktor, et al.. (2014). Mortality of registered drug users in Central Asia. International Journal of Drug Policy. 25(6). 1215–1220. 8 indexed citations
15.
Mravčík, Viktor, et al.. (2013). [Sobering-up stations in the Czech Republic in the context of analogous models of care for acute intoxications in Europe].. PubMed. 152(3). 129–34. 2 indexed citations
16.
Mravčík, Viktor, et al.. (2013). Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Preference and Adherence. 7. 1067–1067. 48 indexed citations
17.
Mravčík, Viktor, et al.. (2011). [Outpatient care for substance users and addicts in the Czech Republic in Health Statistics since 1963].. PubMed. 60(2). 64–73. 1 indexed citations
18.
Sutton, Alex J., Vivian Hope, Catharina Matheï, et al.. (2008). A comparison between the force of infection estimates for blood‐borne viruses in injecting drug user populations across the European Union: a modelling study. Journal of Viral Hepatitis. 15(11). 809–816. 27 indexed citations
19.
Griffiths, Paul, et al.. (2008). Quite a lot of smoke but very limited fire—the use of methamphetamine in Europe. Drug and Alcohol Review. 27(3). 236–242. 45 indexed citations
20.
Zábranský, Tomáš, et al.. (2006). Hepatitis C Virus Infection among Injecting Drug Users in the Czech Republic – Prevalence and Associated Factors. European Addiction Research. 12(3). 151–160. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Montanari Breakdown of academic impact, for papers by Anthea Martin Breakdown of academic impact, for papers by Nelson Arruda Breakdown of academic impact, for papers by Seyed Ramin Radfar Breakdown of academic impact, for papers by Katherine Rudzinski Breakdown of academic impact, for papers by Nicola Metrebian Breakdown of academic impact, for papers by James Fetherston Breakdown of academic impact, for papers by Tomáš Zábranský Breakdown of academic impact, for papers by Ifeoma N. Onyeka Breakdown of academic impact, for papers by G.H.A. van Brussel
Rankless by CCL
2026